[HTML][HTML] Skin cancer classification via convolutional neural networks: systematic review of studies involving human experts
…, C Santonja, D Schadendorf, B Schilling… - European Journal of …, 2021 - Elsevier
Background Multiple studies have compared the performance of artificial intelligence (AI)–based
models for automated skin cancer classification to human experts, thus setting the …
models for automated skin cancer classification to human experts, thus setting the …
Immunotherapy in melanoma: recent advances and future directions
Malignant melanoma contributes the majority of skin cancer related deaths and shows an
increasing incidence in the past years. Despite all efforts of early diagnosis, metastatic …
increasing incidence in the past years. Despite all efforts of early diagnosis, metastatic …
[HTML][HTML] Algorithmic assessment of cellular senescence in experimental and clinical specimens
…, K Evangelou, M Varela-Eirin, J Campisi, B Schilling… - Nature protocols, 2021 - nature.com
The development of genetic tools allowed for the validation of the pro-aging and pro-disease
functions of senescent cells in vivo. These discoveries prompted the development of …
functions of senescent cells in vivo. These discoveries prompted the development of …
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
… (B) Patients were stratified into response groups based on RECIST criteria (21) (CR, complete
response; PR, partial response; SD, stable disease; PD, progressive disease; MR, mixed …
response; PR, partial response; SD, stable disease; PD, progressive disease; MR, mixed …
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
…, JY Henry, EM Van Allen, D Miao, B Schilling… - Science, 2016 - science.org
As tumors grow, they acquire mutations, some of which create neoantigens that influence
the response of patients to immune checkpoint inhibitors. We explored the impact of …
the response of patients to immune checkpoint inhibitors. We explored the impact of …
MicroRNA sequence codes for small extracellular vesicle release and cellular retention
…, TM Zanotto, S Shah, S Kumar Patel, B Schilling… - Nature, 2022 - nature.com
Exosomes and other small extracellular vesicles (sEVs) provide a unique mode of cell-to-cell
communication in which microRNAs (miRNAs) produced and released from one cell are …
communication in which microRNAs (miRNAs) produced and released from one cell are …
Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma
Verification of candidate biomarkers relies upon specific, quantitative assays optimized for
selective detection of target proteins, and is increasingly viewed as a critical step in the …
selective detection of target proteins, and is increasingly viewed as a critical step in the …
[PDF][PDF] A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade
…, MS Kowalczyk, I Cañadas, B Schilling… - Cell, 2018 - cell.com
… (B) Method to discover malignant cell programs associated with immune cell infiltration or
exclusion. (C and D) Distinct profiles of malignant and non-malignant cells. t-stochastic …
exclusion. (C and D) Distinct profiles of malignant and non-malignant cells. t-stochastic …
[HTML][HTML] Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
… (for example, B cell markers enriched in ipilimumab-experienced responders) in ICB response,
consistent with data from a recent trial demonstrating higher B cell infiltrate in responders …
consistent with data from a recent trial demonstrating higher B cell infiltrate in responders …
[HTML][HTML] A proteomic atlas of senescence-associated secretomes for aging biomarker development
…, V Sharma, L Ferrucci, J Campisi, B Schilling - PLoS …, 2020 - journals.plos.org
The senescence-associated secretory phenotype (SASP) has recently emerged as a driver
of and promising therapeutic target for multiple age-related conditions, ranging from …
of and promising therapeutic target for multiple age-related conditions, ranging from …